Header image: Adobe Stock

Category: News

Five of Plougmann Vingtoft’s experts ranked as IP Stars 2022

Managing IP just published this year’s list of the industry’s most skilled IP advisors. Five of Plougmann Vingtoft’s experts are on […]

Gavel in front of EU flag

Plougmann Vingtoft is ready for the new European patent system

Preparations ahead of the new European patent system are in full swing and we are ready to help with the transition. Read more […]

Managing IP recognizes Plougmann Vingtoft’s trademark team

The trademark team at Plougmann Vingtoft has achieved a distinguished position in Tier 2 in this year’s MIP rankings […]

Plougmann Vingtoft donates to Unicef’s humanitarian efforts in Ukraine

Millions of people are fleeing the war in Ukraine . To help with the humanitarian efforts, Plougmann Vingtoft makes a donation to Unicef […].

Hand holding glass globe

Plougmann Vingtoft supports the sustainable businesses of the future

At Plougmann Vingtoft, we wish to support businesses that are trying to make a sustainable difference. Read more […]

Uvisa Health - the winners of IP Matters 2021

Uvisa Health wins IP Matters 2021

Every year through to 2030, Plougmann Vingtoft donates IP consulting in conjunction with DanBan to a start-up that we consider to be able to influence one or more of the UN SDGs. This year’s winner has just been announced.

Plougmann Vingtoft takes gold in 2021 IAM Patent 1000

IAM Patent 1000 has now revealed its rankings for 2021. Once again, Plougmann Vingtoft ranks among the world’s elite IP consultancies […]

EU fund urges SMEs to incorporate IPR

Many SMEs don’t prioritise IPR early enough. Through an IP fund, EUIPO now seeks to change this. Don’t miss out on the last application window in 2021.

Plougmann Vingtoft among the world’s best IP consultancies

Plougmann Vingtoft retains a position as a Top Tier firm for patent and trademark work. See the full list of top tier IP firms here [..]

vaccine patents

3 reasons why politicians should not waive vaccine patents

Would it be an advantage to waive vaccine patents? The idea may sound attractive, but the short answer is no, and here is why […]